医学
宫颈癌
人口
肺癌
肿瘤科
癌症
内科学
环境卫生
作者
Krishnansu S. Tewari,Bradley J. Monk,Ignace Vergote,Austin Miller,Andréia Cristina de Melo,Hee‐Seung Kim,Yong Man Kim,Alla Lisyanskaya,Vanessa Samouëlian,Domenica Lorusso,Fernanda Damian,Chih‐Long Chang,Evgeniy A. Gotovkin,Shunji Takahashi,Daniella Ramone,Joanna Pikiel,Beata Maćkowiak-Matejczyk,Eva Maria Guerra Alía,Nicoletta Colombo,Yulia Makarova
标识
DOI：10.1056/nejmoa2112187
摘要
Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)–blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in this population.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
鬼笔环肽
唐泽雪穗
HybirdCell
eric888
Criminology34
遇上就这样吧
哈基米德
nenoaowu
tuanheqi
andrele
虾青素
馆长
好椰
竹筏过海
核桃
查理
香蕉觅云
斯寜
老阎
生椰拿铁死忠粉
啊啊啊哈哈哈呜呜呜
包子吃多了
morena
ccczzz
Dai
Marciu33
共享精神
皖公网安备34019202002308
